Amgen Inc. (AMGN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Amgen Inc. (AMGN)

AMGN 345.46

+0.3%

Nov 28 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: JohnP who wrote (652)	10/23/1998 9:54:00 AM
From: Machaon	Read Replies (1) of 1906

Off Topic: << I have taken the Carticel implantation course in Cambridge MA and feel this procedure has a lot of promise for certain articular cartilage defects. >> Do you have any views on why the Carticel growth rate isn't higher? Genzyme Tissue estimates that there are about 95,000 annual cartilage injuries to femur articular cartilage, and another 20,000 to 30,000 patients, per year, that have failures from other procedures. Genzyme performed 209 US procedures in the 3rd quarter, or about 0.2% of the total annual potential. TIA, Bob

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next